What is Neuramis Light® Hyaluronic Acid Dermal Filler with Lidocaine?
Neuramis Light / Meso with Lidocaine is made up of two-time cross-linked Hyaluronic Acid. That makes this pioneering soft-tissue filler more stable and robust compared to its market rivals. When injected into the middle dermis, it instantly fills wrinkles and folds and delivers extra volume under the skin, giving the face a smoother and rejuvenated appearance.
Because of all that, patients can expect to immediately see the results of their anti-aging treatment. Even the more pronounced wrinkles on the face and under the eyes will be corrected in an instant. HA also has powerful moisturizing capabilities that will gradually improve the tonicity and elasticity of the skin.
Benefits of Neuramis Light® Hyaluronic Acid Dermal Filler with Lidocaine
- The most comfortable procedure – lidocaine, which is part of Neuramis Light Lidocaine, has an analgesic effect, making the procedure as comfortable as possible for patients.
- The high degree of purification – thanks to the unique SHAPE technology, characterized by a 2-stage cross-linking process and an increased process of hyaluronic acid purification, Neuramis Light Lidocaine is a reliable and effective product. Ideal for correcting deep wrinkles and restoring lost volume.
- Fast and safe result – the effect of Neuramis Light Lidocaine is noticeable immediately after the procedure, and a significant improvement in the structure and elasticity of the skin is achieved, as well as the replenishment of the lost volume.
- Easy to use – ultra-thin needles manufactured by the Japanese company TSK Laboratory, as well as the plasticity of hyaluronic acid, guarantee ease of use and natural shapes.
- Top quality – Neuramis Light Lidocaine uses hyaluronic acid supplied by a Japanese company (Shiseido), the safety of which has been confirmed by the US Food and Drug Administration (FDA) and the European Administration for Quality Assurance of Medical Services and Medicines.
- Long-term effect – the duration is up to 12 months, depending on the characteristics of the patient.